91 related articles for article (PubMed ID: 25109)
21. The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
Agid Y; Graybiel AM; Ruberg M; Hirsch E; Blin J; Dubois B; Javoy-Agid F
Adv Neurol; 1990; 53():83-100. PubMed ID: 1978522
[No Abstract] [Full Text] [Related]
22. [Abnormal neurotransmission in neurological diseases (author's transl)].
Toru M
Tanpakushitsu Kakusan Koso; 1979; 24(2):150-9. PubMed ID: 35816
[No Abstract] [Full Text] [Related]
23. Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease.
Elsworth JD; Roth RH
Exp Neurol; 1997 Mar; 144(1):4-9. PubMed ID: 9126143
[TBL] [Abstract][Full Text] [Related]
24. Neural degeneration and the transport of neurotransmitters.
Edwards RH
Ann Neurol; 1993 Nov; 34(5):638-45. PubMed ID: 7902065
[TBL] [Abstract][Full Text] [Related]
25. [Mechanisms and treatments of Parkinson disease].
Pollak P
Rev Prat; 1997 May; 47(10):1068-76. PubMed ID: 9208669
[TBL] [Abstract][Full Text] [Related]
26. Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism.
Kito S; Miyoshi R; Mizuno K; Nitta K; Matsubayashi H; Yamamura Y; Tahara E
Adv Neurol; 1987; 45():159-65. PubMed ID: 2881441
[No Abstract] [Full Text] [Related]
27. Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease.
Benedetto A; Au C; Aschner M
Chem Rev; 2009 Oct; 109(10):4862-84. PubMed ID: 19534496
[No Abstract] [Full Text] [Related]
28. The pathochemical perspectives of Parkinson's disease. An attempt at a neurochemical definition.
Hornykiewicz O
Funct Neurol; 1988; 3(4):379-91. PubMed ID: 3072274
[No Abstract] [Full Text] [Related]
29. Neurotransmitter interactions related to central dopamine neurons.
Lloyd KG
Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
[No Abstract] [Full Text] [Related]
30. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in Parkinson's disease.
Vécsei L
Ideggyogy Sz; 2002 Nov; 55(11-12):406-7. PubMed ID: 12632802
[No Abstract] [Full Text] [Related]
32. [Striatal dopamine availability in Parkinson's disease--with reference to the wearing-off phenomenon].
Indo T
Rinsho Shinkeigaku; 1984 Oct; 24(10):1008-16. PubMed ID: 6518691
[No Abstract] [Full Text] [Related]
33. [Parkinson's disease].
de Saxce H
Rev Infirm; 1979 Jan; 29(1):50-7. PubMed ID: 252780
[No Abstract] [Full Text] [Related]
34. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.
Sossi V; de la Fuente-Fernández R; Schulzer M; Troiano AR; Ruth TJ; Stoessl AJ
Ann Neurol; 2007 Nov; 62(5):468-74. PubMed ID: 17886297
[TBL] [Abstract][Full Text] [Related]
35. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.
Price KS; Farley IJ; Hornykiewicz O
Adv Biochem Psychopharmacol; 1978; 19():293-300. PubMed ID: 696462
[No Abstract] [Full Text] [Related]
36. Dopaminergic innervation of the human striatum in Parkinson's disease.
Papapetropoulos S; Basel M; Mash DC
Mov Disord; 2007 Jan; 22(2):286-8. PubMed ID: 17083095
[No Abstract] [Full Text] [Related]
37. [Biochemistry of neuronal transmission. Pharmacology of parkinsonism].
Lombardo L
Gac Med Mex; 1981 Dec; 117(12):476-8. PubMed ID: 6123462
[No Abstract] [Full Text] [Related]
38. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
[TBL] [Abstract][Full Text] [Related]
39. Comment on the commonality of manganese neurotoxicity and Parkinson's disease.
Graham DG
Neurotoxicology; 1981 Oct; 2(2):387-8. PubMed ID: 7198760
[No Abstract] [Full Text] [Related]
40. [Influencing of Parkinson's syndrome via intervention in the dopamine metabolism].
Korten JJ; van Rossum JM
Ned Tijdschr Geneeskd; 1973 Feb; 117(8):296-305. PubMed ID: 4350090
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
